Disclosures for "A New Era in the Management of Rett Syndrome: Are Neurologists Ready for a Changing Management Landscape?")
-
Dr. Compton has nothing to disclose.
-
Carole Drexel has nothing to disclose.
-
Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.
-
Mrs. Nues has received personal compensation for serving as an employee of International Rett Syndrome Foundation.